The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial
about
The ancient drug salicylate directly activates AMP-activated protein kinaseNatural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a TargetEffects of NSAIDs on the risk factors of colorectal cancer: a mini reviewHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsDiabetic Cardiovascular Disease Induced by Oxidative StressThe role of fatty acids in insulin resistanceThe effect of periodontal treatment on hemoglobin a1c levels of diabetic patients: a systematic review and meta-analysisTargeting inflammation in diabetes: Newer therapeutic optionsIslet inflammation: a unifying target for diabetes treatment?Something old, something new and something very old: drugs for treating type 2 diabetesThe outliers become a stampede as immunometabolism reaches a tipping pointRegenerative therapies for diabetic microangiopathyImplication of inflammatory signaling pathways in obesity-induced insulin resistancePsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorObesity: An Immunometabolic PerspectiveSalicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitizationSalicylate prevents virus-induced type 1 diabetes in the BBDR ratRegulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazoneSalicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activityCellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistanceInflammation-induced microvascular insulin resistance is an early event in diet-induced obesitySalsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humansInvestigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.A Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsWhat causes the insulin resistance underlying obesity?AMPK activation--protean potential for boosting healthspan.Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controlsAdipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes.Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis.First anti-inflammatory generic drug promising new therapy for diabetes.Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.Metabolic heterogeneity of obesity: role of adipose tissue.B lymphocytes as emerging mediators of insulin resistance.The effect of salsalate on biochemical factors and endothelial dysfunction of prediabetic patients: A randomized clinical trialSalicylate (salsalate) in patients with type 2 diabetes: a randomized trial.Anti-inflammatory therapies for cardiovascular diseaseAn inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceAnti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
P2860
Q24630758-D1C55558-0B74-4C72-A7C7-19F4172C16A8Q26741391-69B96F57-6067-412E-8606-BDE0DC66BB32Q26746884-C4C89566-69D1-433E-9D6C-5821BB347527Q26774658-C2290567-4339-4CB0-A797-C830CF8A1BACQ26778017-E36461D3-5F93-4476-BA88-2B0109A31DADQ26785440-0C9D5116-98F0-4118-892B-ABAC649D728EQ26822372-FEE8E2FB-94E9-49B0-85B0-A9CD094141C1Q26852726-59320A98-B89D-4F02-ACA0-BF7683E22389Q26860847-A4BE5582-E872-47A8-AD4F-ABB87E30B6A8Q26865663-DD12361F-3BFB-4397-8071-E44140F36ED5Q27005951-978D054E-A7F9-42DD-805A-631B29B2B78FQ27027852-E39C0582-DF19-4D97-AF4D-FDFC55675037Q27500365-2D57B128-BC0E-4EEB-959F-FD267BFE4855Q27694728-9131B32A-F169-4C33-B4FA-4BCE6C31D157Q28072140-0A6E9973-8681-45DC-A026-7829A59EC4A0Q28260504-FADEECEA-5745-47CC-A6B2-33D2BBAA5F04Q28534436-24628ACA-D644-48CB-9240-300BAEF98FF6Q28537905-5D3924E9-EC8A-4895-9E52-8DC16913274BQ28831354-6D842CE9-68C5-4901-8DAA-CA15B2CEE0C3Q30009848-4BBB8E38-8FD3-4C4A-BD12-A81215CF7005Q30278865-19552CB8-66A8-4DF2-9FBE-F364CCD5720FQ30426185-B499F09F-D324-46E0-AA1E-7C69FE753ED6Q30426407-45F69B7F-8E0A-47EF-AEA5-112D77E318D4Q33585792-0A8D474F-40BA-458A-8550-7D4C8C8562FEQ33624371-BBE49A98-FDC3-4020-A0C4-0543EE340FB5Q33625958-BF8D04D8-1915-47C3-84CC-B305CE863ADCQ33684984-6BE31EE8-3486-4395-BFB3-A72CC3D3AB9BQ33689169-4FD63559-A2B6-46F7-853E-D5F0A4D95014Q33769258-64EBFAB2-B3B7-4864-B46F-54C8DC799EAAQ33862296-A90AC09B-E4C7-4748-B6BE-13621D092AB8Q33909300-ACCF7981-BA8B-419C-9F5E-4A4F1C8CDD86Q33932051-931B55A6-7805-4D9B-AB25-CC3A1B09968FQ33932928-001EDC26-98D9-4646-A62E-EBB4E57BB4ACQ33942543-07962E7F-DA40-45FD-AB0B-E89E63BB5F0EQ33942560-2304B36A-36D1-4850-888B-0DD880684306Q33970976-24C3F792-E5C0-4C2C-8C0A-AFB0D292187AQ34027442-95266614-91CE-48F6-BD0D-E6D55DF25712Q34137872-B556096F-F0D6-43E5-AAAC-345F325CD53BQ34327061-618E803E-DCB6-4E17-BC7B-3295BAD39E03Q34444895-D8D8B5B8-B268-47D2-96D8-A278D4EC36FD
P2860
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@ast
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@en
type
label
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@ast
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@en
prefLabel
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@ast
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@en
P2093
P2860
P1476
The effects of salsalate on gl ...... 2 diabetes: a randomized trial
@en
P2093
Allison B Goldfine
Kathleen A Jablonski
Laura Pyle
Myrlene A Staten
Steven E Shoelson
TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team
Vivian Fonseca
P2860
P304
P356
10.7326/0003-4819-152-6-201003160-00004
P407
P577
2010-03-01T00:00:00Z